People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Capricor Therapeutics, Inc. | — | Biotechnology | Series B | $51.9M | $147.2M | 2013 |
| Lucina Health, Inc. | — | Healthtech | Seed | $24.0M | $50.1M | 2010 |
| Isto Technologies Inc | — | Biotechnology | Series A | $21.1M | $88.9M | 2014 |
| Akadeum Life Sciences, Inc. | — | Other Health Care | Series A | $15.4M | $20.5M | 2023 |
| Accuri Cytometers Inc | — | Other Health Care | Series A | $9.7M | $121.1M | 2009 |
George Dunbar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside George Dunbar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Petersen | 2 | 9 |
| Michael Ross | 1 | 18 |
| Paul Brown | 1 | 12 |
| Tara Butler | 1 | 12 |
| Robert Weisskoff | 1 | 12 |
| Joshua A. Kazam | 1 | 10 |
| Jeffrey Williams | 1 | 10 |
| Wright Steenrod | 1 | 9 |
| William Wood | 1 | 9 |
| David M. Tanen | 1 | 8 |
| Harry Wilcox | 1 | 6 |
| Koleman Karleski | 1 | 5 |
| Arie S. Belldegrun | 1 | 5 |
| Peter Shagory | 1 | 5 |
| Timothy B. Petersen | 1 | 5 |
| Joshua Kazam | 1 | 5 |
| Paul D'Amato | 1 | 4 |
| Paul A. Mieyal | 1 | 4 |
| Cheryl R. Blanchard | 1 | 4 |
| W. Earl Reed III | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.